CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Serial seroconversion measurements in hospital employees during the COVID-19 pandemicWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2985 research specific blood sample Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic

The aim of this study is to apply serology testing methods for SARS-CoV2 antibodies in samples collected from HCWs in an acute hospital. This will enable the identification of those who are protected and non-infectious for SARS-CoV2 and those who are seronegative and therefore potentially susceptible and infectious on patient contact. Prospective testing will provide data on the acquisition of SARS-CoV2 infections among HCWs and associated risk factors for transmission during a pandemic at an acute care hospital facility in the capital region of Denmark. Hypothesis: Serial seroconversion measurements in hospital employees improve the organization of the clinical treatment and care during the COVID-19 pandemic at Nordsjællands Hospital and Nykøbing Falster County Hospital.

NCT04431310 Covid-19 Health Personnel Personnel, Hospital Other: Serial seroconversion measurements in hospital employees during the COVID-19 pandemic

Primary Outcomes

Description: IgM and IgG (Covid-19 antibodies)

Measure: Serology testing for specific COVID-19

Time: From baseline to follow up at four years

Secondary Outcomes

Description: Swab, SARS-CoV-2

Measure: SARS-CoV-2 infection

Time: From baseline to follow up at three months

Other Outcomes

Description: Age, gender, employment details, smoking, chronic diseases

Measure: Co-variates

Time: At baseline


No related HPO nodes (Using clinical trials)